SCHEMBL3492841

SCHEMBL3492841

N=C(N)c1cc(N2CC2)c([N+](=O)[O-])cc1[N+](=O)[O-]

nearest known ligand 0.75

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 15/20 0.75
CYP3A4 P08684 1/20 0.75
BLM P54132 1/20 0.75
PMP22 Q01453 1/20 0.75
GAA P10253 4/20 0.47
LMNA P02545 3/20 0.47
HTT P42858 2/20 0.47
ALDH1A1 P00352 11/20 0.46
L3MBTL1 Q9Y468 3/20 0.46
PKM P14618 1/20 0.46
MEN1 O00255 3/20 0.44
KMT2A Q03164 3/20 0.44
MAPK1 P28482 1/20 0.44
CYP1A2 P05177 2/20 0.43
CYP2C19 P33261 2/20 0.43
CYP2D6 P10635 1/20 0.43
CYP2C9 P11712 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
CTPS1 P17812 1/20 0.42
POLB P06746 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Tretazicar SCHEMBL29375352 0.86 MAPT (1.00) MAPTCYP3A4BLMPMP22GAA
Tretazicar SCHEMBL366755 0.86 MAPT (1.00) MAPTCYP3A4BLMPMP22GAA
SCHEMBL11120951 0.81 MAPT (0.74) MAPTCYP3A4BLMPMP22GAA
SCHEMBL13685668 0.77 MAPT (0.78) MAPTCYP3A4BLMPMP22GAA
SCHEMBL5827945 0.77 MAPT (0.78) MAPTCYP3A4BLMPMP22GAA
SCHEMBL5827633 0.76 MAPT (0.67) MAPTCYP3A4BLMPMP22GAA
SCHEMBL5581335 0.74 MAPT (0.78) MAPTCYP3A4BLMPMP22GAA
SCHEMBL3678573 0.74 MAPT (0.72) MAPTCYP3A4BLMPMP22GAA
SCHEMBL28153041 0.72 KDM4E (0.61) MAPTCYP3A4BLMPMP22GAA
Tretazicar SCHEMBL5805671 0.71 MAPT (0.69) MAPTCYP3A4BLMPMP22GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100075414-A1 GROWTH OF FOREIGN CELLS AFTER CONDITIONAL AND SELECTIVE DESTRUCTION OF FETAL HOST CELLS XIMEREX, INC. (US) 2010-03-25 US disclosed
US-7626075-B2 Growth of foreign cells in fetal animals facilitated by conditional and selective destruction of native host cells XIMEREX, INC. (US) 2009-12-01 US disclosed
EP-1855534-A4 FACILITATED CELLULAR RECONSTITUTION OF ORGANS AND TISSUES DIAMOND PAUL (US) 2008-12-17 EP disclosed
EP-1855534-A2 FACILITATED CELLULAR RECONSTITUTION OF ORGANS AND TISSUES Diamond, Paul (US) 2007-11-21 EP disclosed
US-20070240235-A1 METHODS FOR SUPPORTING AND PRODUCING HUMAN CELLS AND TISSUES IN NON-HUMAN MAMMAL HOSTS DIAMOND PAUL 2007-10-11 US disclosed
US-20070134212-A1 Growth of foreign cells in fetal animals facilitated by conditional and selective destruction of native host cells XIMEREX, INC. (US) 2007-06-14 US disclosed
WO-2006074012-A2 FACILITATED CELLULAR RECONSTITUTION OF ORGANS AND TISSUES DIAMOND PAUL (US) 2006-07-13 WO disclosed
WO-2006072018-A2 METHODS FOR SUPPORTING AND PRODUCING HUMAN CELLS AND TISSUES IN NON-HUMAN MAMMAL HOSTS DIAMOND PAUL (US) 2006-07-06 WO disclosed
US-20060147429-A1 FACILITATED CELLULAR RECONSTITUTION OF ORGANS AND TISSUES DIAMOND PAUL 2006-07-06 US disclosed
US-20060148080-A1 METHODS FOR SUPPORTING AND PRODUCING HUMAN CELLS AND TISSUES IN NON-HUMAN MAMMAL HOSTS DIAMOND PAUL 2006-07-06 US disclosed
EP-1545215-A2 GROWTH OF FOREIGN CELLS IN FETAL ANIMALS FACILITATED BY CONDITIONAL AND SELECTIVE DESTRUCTION OF NATIVE HOST CELLS Ximerex, Inc. (US) 2005-06-29 EP disclosed
WO-2004027029-A2 GROWTH OF FOREIGN CELLS IN FETAL ANIMALS FACILITATED BY CONDITIONAL AND SELECTIVE DESTRUCTION OF NATIVE HOST CELLS XIMEREX, INC. (US) 2004-04-01 WO disclosed